Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles. 2014

Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
Dipartimento di Scienze Chimiche e Farmaceutiche, Università di Ferrara , Ferrara, Italy.

A new class of compounds that incorporated the structural motif of the 1-(3',4',5'-trimethoxtbenzoyl)-3-arylamino-5-amino-1,2,4-triazole molecular skeleton was synthesized and evaluated for their antiproliferative activity in vitro, interactions with tubulin, and cell cycle effects. The most active agent, 3c, was evaluated for antitumor activity in vivo. Structure-activity relationships were elucidated with various substituents on the phenyl ring of the anilino moiety at the C-3 position of the 1,2,4-triazole ring. The best results for inhibition of cancer cell growth were obtained with the p-Me, m,p-diMe, and p-Et phenyl derivatives 3c, 3e, and 3f, respectively, and overall, these compounds were more or less as active as CA-4. Their vascular disrupting activity was evaluated in HUVEC cells, with compound 3c showing activity comparable with that of CA-4. Compound 3c almost eliminated the growth of syngeneic hepatocellular carcinoma in Balb/c mice, suggesting that 3c could be a new antimitotic agent with clinical potential.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 1994, Pharmacological research,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 2010, Iranian journal of pharmaceutical research : IJPR,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 2011, Indian journal of pharmaceutical sciences,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
March 1978, Chemical & pharmaceutical bulletin,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
December 1991, Arzneimittel-Forschung,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
July 1987, Il Farmaco; edizione scientifica,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 2011, Arzneimittel-Forschung,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 1998, Pharmaceutica acta Helvetiae,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
January 2002, Arzneimittel-Forschung,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Kimatrai Salvador, and Filippo Prencipe, and Valerio Bertolasi, and Michela Cancellieri, and Andrea Brancale, and Ernest Hamel, and Ignazio Castagliuolo, and Francesca Consolaro, and Elena Porcù, and Giuseppe Basso, and Giampietro Viola
February 1989, Archiv der Pharmazie,
Copied contents to your clipboard!